{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T13:15:33Z","timestamp":1761311733949},"reference-count":32,"publisher":"Japanese Association for Laboratory Animal Science","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp. Anim."],"published-print":{"date-parts":[[2021]]},"DOI":"10.1538\/expanim.20-0113","type":"journal-article","created":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T22:07:00Z","timestamp":1612303620000},"page":"245-256","source":"Crossref","is-referenced-by-count":3,"title":["2,4,6-trinitrobenzenesulfonic acid-induced colitis in <i>Rattus norgevicus<\/i>: a categorization proposal"],"prefix":"10.1538","volume":"70","author":[{"given":"Mariana","family":"Ferreira-Duarte","sequence":"first","affiliation":[{"name":"Laboratory of Pharmacology, Department of Drug Sciences, Faculty of Pharmacy of University of Porto (FFUP), 4050-313, Portugal"},{"name":"LAQV@REQUIMTE, University of Porto, 4050-313, Portugal"}]},{"given":"Tiago","family":"Rodrigues-Pinto","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacology, Department of Drug Sciences, Faculty of Pharmacy of University of Porto (FFUP), 4050-313, Portugal"}]},{"given":"Daniela","family":"Menezes-Pinto","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacology, Department of Drug Sciences, Faculty of Pharmacy of University of Porto (FFUP), 4050-313, Portugal"}]},{"given":"Marisa","family":"Esteves-Monteiro","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacology, Department of Drug Sciences, Faculty of Pharmacy of University of Porto (FFUP), 4050-313, Portugal"}]},{"given":"Salom\u00e9","family":"Gon\u00e7alves-Monteiro","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacology, Department of Drug Sciences, Faculty of Pharmacy of University of Porto (FFUP), 4050-313, Portugal"},{"name":"LAQV@REQUIMTE, University of Porto, 4050-313, Portugal"}]},{"given":"Sara","family":"Capas-Peneda","sequence":"additional","affiliation":[{"name":"Laboratory Animal Science, IBMC, University of Porto, 4200-135, Portugal"}]},{"given":"Fernando","family":"Magro","sequence":"additional","affiliation":[{"name":"Department of Biomedicine, Pharmacology and Therapeutics Unit, Faculty of Medicine, University of Porto, 4200-319, Portugal"}]},{"given":"Patr\u00edcia","family":"Dias-Pereira","sequence":"additional","affiliation":[{"name":"Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar, University of Porto (ICBAS-UP), 4050-313, Portugal"}]},{"given":"Manuela","family":"Morato","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacology, Department of Drug Sciences, Faculty of Pharmacy of University of Porto (FFUP), 4050-313, Portugal"},{"name":"LAQV@REQUIMTE, University of Porto, 4050-313, Portugal"}]},{"given":"Margarida","family":"Duarte-Ara\u00fajo","sequence":"additional","affiliation":[{"name":"LAQV@REQUIMTE, University of Porto, 4050-313, Portugal"},{"name":"Department of Immuno-Physiology and Pharmacology, ICBAS-UP, 4050-313, Portugal"}]}],"member":"439","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Bramhall M, Fl\u00f3rez-Vargas O, Stevens R, Brass A, Cruickshank S. Quality of methods reporting in animal models of colitis. Inflamm Bowel Dis.  2015;  21: 1248\u20131259.","DOI":"10.1097\/MIB.0000000000000369"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Zeeff SB, Kunne C, Bouma G, de Vries RB, Te Velde AA. Actual Usage and Quality of Experimental Colitis Models in Preclinical Efficacy Testing: A Scoping Review. Inflamm Bowel Dis.  2016;  22: 1296\u20131305.","DOI":"10.1097\/MIB.0000000000000758"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet.  2018;  390: 2769\u20132778.","DOI":"10.1016\/S0140-6736(17)32448-0"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Dothel G, Vasina V, Barbara G, De Ponti F. Animal models of chemically induced intestinal inflammation: predictivity and ethical issues. Pharmacol Ther.  2013;  139: 71\u201386.","DOI":"10.1016\/j.pharmthera.2013.04.005"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ferri D, Costero AM, Gavi\u00f1a P, Parra M, Merino V, Teruel AH, et al. Efficacy of budesonide-loaded mesoporous silica microparticles capped with a bulky azo derivative in rats with TNBS-induced colitis. Int J Pharm.  2019;  561: 93\u2013101.","DOI":"10.1016\/j.ijpharm.2019.02.030"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Seoane-Via\u00f1o I, G\u00f3mez-Lado N, L\u00e1zare-Iglesias H, Barreiro-de Acosta M, Silva-Rodr\u00edguez J, Luzardo-\u00c1lvarez A, et al. Longitudinal PET\/CT evaluation of TNBS-induced inflammatory bowel disease rat model. Int J Pharm.  2018;  549: 335\u2013342.","DOI":"10.1016\/j.ijpharm.2018.08.005"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Antoniou E, Margonis GA, Angelou A, Pikouli A, Argiri P, Karavokyros I, et al. The TNBS-induced colitis animal model: An overview. Ann Med Surg (Lond).  2016;  11: 9\u201315.","DOI":"10.1016\/j.amsu.2016.07.019"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Yousefi-Ahmadipour A, Rashidian A, Mirzaei MR, Farsinejad A, PourMohammadi-Nejad F, Ghazi-Khansari M, et al. Combination therapy of mesenchymal stromal cells and sulfasalazine attenuates trinitrobenzene sulfonic acid induced colitis in the rat: The S1P pathway. J Cell Physiol.  2019;  234: 11078\u201311091.","DOI":"10.1002\/jcp.27944"},{"key":"9","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/0016-5085(89)90904-9","volume":"96","year":"1989","unstructured":"9. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology.  1989;  96: 795\u2013803.","journal-title":"Gastroenterology","ISSN":"http:\/\/id.crossref.org\/issn\/0016-5085","issn-type":"print"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Appleyard CB, Wallace JL. Reactivation of hapten-induced colitis and its prevention by anti-inflammatory drugs. Am J Physiol.  1995;  269: G119\u2013G125.","DOI":"10.1152\/ajpgi.1995.269.1.G119"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Zizzo MG, Auteri M, Amato A, Caldara G, Nuzzo D, Di Carlo M, et al. Angiotensin II type II receptors and colonic dysmotility in 2,4-dinitrofluorobenzenesulfonic acid-induced colitis in rats. Neurogastroenterol Motil.  2017;  29: e13019.","DOI":"10.1111\/nmo.13019"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Brenna \u00d8, Furnes MW, Drozdov I, van Beelen Granlund A, Flatberg A, Sandvik AK, et al. Relevance of TNBS-colitis in rats: a methodological study with endoscopic, histologic and Transcriptomic [corrected] characterization and correlation to IBD. PLoS One.  2013;  8: e54543.","DOI":"10.1371\/journal.pone.0054543"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Fentener van Vlissingen JM, Borrens M, Girod A, Lelovas P, Morrison F, Torres YS. The reporting of clinical signs in laboratory animals: FELASA Working Group Report. Lab Anim.  2015;  49: 267\u2013283.","DOI":"10.1177\/0023677215584249"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Lazic SE, Essioux L. Improving basic and translational science by accounting for litter-to-litter variation in animal models. BMC Neurosci.  2013;  14: 37.","DOI":"10.1186\/1471-2202-14-37"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Dignass A, Eliakim R, Magro F, Maaser C, Chowers Y, Geboes K, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis. J Crohn\u2019s Colitis.  2012;  6: 965\u2013990.","DOI":"10.1016\/j.crohns.2012.09.003"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Sotocinal SG, Sorge RE, Zaloum A, Tuttle AH, Martin LJ, Wieskopf JS, et al. The Rat Grimace Scale: a partially automated method for quantifying pain in the laboratory rat via facial expressions. Mol Pain.  2011;  7: 55.","DOI":"10.1186\/1744-8069-7-55"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Festing MF. On determining sample size in experiments involving laboratory animals. Lab Anim.  2018;  52: 341\u2013350.","DOI":"10.1177\/0023677217738268"},{"key":"18","unstructured":"18. Zhao P, Guan H, Dong L, Luo J, Gong J. Role of mast cells and eosinophils in different stages of trinitrobenzenosulphonic acid-induced rat colitis. Int J Clin Exp Pathol.  2019;  12: 498\u2013506."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Petrella C, Giuli C, Broccardo M, Eutamene H, Cartier C, Leveque M, et al. Protective and worsening peripheral nociceptin\/orphanin FQ receptor-mediated effect in a rat model of experimental colitis. Pharmacol Res.  2013;  70: 72\u201379.","DOI":"10.1016\/j.phrs.2013.01.004"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Bernstein CN, Eliakim A, Fedail S, Fried M, Gearry R, Goh KL, et al. Review Team. World Gastroenterology Organisation Global Guidelines Inflammatory Bowel Disease: Update August 2015. J Clin Gastroenterol.  2016;  50: 803\u2013818.","DOI":"10.1097\/MCG.0000000000000660"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Jauregui-Amezaga A, Geerits A, Das Y, Lemmens B, Sagaert X, Bessissow T, et al. A Simplified Geboes Score for Ulcerative Colitis. J Crohn\u2019s Colitis.  2017;  11: 305\u2013313.","DOI":"10.1093\/ecco-jcc\/jjw154"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Magro F, Langner C, Driessen A, Ensari A, Geboes K, Mantzaris GJ, et al. European Society of Pathology (ESP)European Crohn\u2019s and Colitis Organisation (ECCO). European consensus on the histopathology of inflammatory bowel disease. J Crohn\u2019s Colitis.  2013;  7: 827\u2013851.","DOI":"10.1016\/j.crohns.2013.06.001"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Mohammed N, Subramanian V. Clinical relevance of endoscopic assessment of inflammation in ulcerative colitis: Can endoscopic evaluation predict outcomes? World J Gastroenterol.  2016;  22: 9324\u20139332.","DOI":"10.3748\/wjg.v22.i42.9324"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Shah MK, Wan J, Janyaro H, Tahir AH, Cui L, Ding MX. Visceral Hypersensitivity Is Provoked by 2,4,6-Trinitrobenzene Sulfonic Acid-Induced Ileitis in Rats. Front Pharmacol.  2016;  7: 214.","DOI":"10.3389\/fphar.2016.00214"},{"key":"25","unstructured":"25. Motavallian-Naeini A, Andalib S, Rabbani M, Mahzouni P, Afsharipour M, Minaiyan M. Validation and optimization of experimental colitis induction in rats using 2, 4, 6-trinitrobenzene sulfonic acid. Res Pharm Sci.  2012;  7: 159\u2013169."},{"key":"26","unstructured":"26. Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest.  1993;  69: 238\u2013249."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Cai Y, Liu W, Lin Y, Zhang S, Zou B, Xiao D, et al. Compound polysaccharides ameliorate experimental colitis by modulating gut microbiota composition and function. J Gastroenterol Hepatol.  2019;  34: 1554\u20131562.","DOI":"10.1111\/jgh.14583"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Pohlmann A, Tilling LC, Robinson A, Woolmer O, McCleary S, Kruidenier L, et al. Progression and variability of TNBS colitis-associated inflammation in rats assessed by contrast-enhanced and T2-weighted MRI. Inflamm Bowel Dis.  2009;  15: 534\u2013545.","DOI":"10.1002\/ibd.20800"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Miller AL, Leach MC. The Mouse Grimace Scale: A Clinically Useful Tool? PLoS One.  2015;  10: e0136000.","DOI":"10.1371\/journal.pone.0136000"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Sperry MM, Yu YH, Welch RL, Granquist EJ, Winkelstein BA. Grading facial expression is a sensitive means to detect grimace differences in orofacial pain in a rat model. Sci Rep.  2018;  8: 13894.","DOI":"10.1038\/s41598-018-32297-2"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Leung V, Zhang E, Pang DS. Real-time application of the Rat Grimace Scale as a welfare refinement in laboratory rats. Sci Rep.  2016;  6: 31667.","DOI":"10.1038\/srep31667"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Onori L, Aggio A, D\u2019Alo\u2019 S, Muzi P, Cifone MG, Mellillo G, et al. Role of nitric oxide in the impairment of circular muscle contractility of distended, uninflamed mid-colon in TNBS-induced acute distal colitis in rats. World J Gastroenterol.  2005;  11: 5677\u20135684.","DOI":"10.3748\/wjg.v11.i36.5677"}],"container-title":["Experimental Animals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/expanim\/70\/2\/70_20-0113\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T03:39:16Z","timestamp":1621049956000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/expanim\/70\/2\/70_20-0113\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1538\/expanim.20-0113","relation":{},"ISSN":["1341-1357","1881-7122"],"issn-type":[{"value":"1341-1357","type":"print"},{"value":"1881-7122","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]}}}